Coherus BioSciences
CHRS
#8264
Rank
ยฃ99.19 M
Marketcap
ยฃ0.86
Share price
7.62%
Change (1 day)
-76.81%
Change (1 year)

Revenue for Coherus BioSciences (CHRS)

Revenue in 2024 (TTM): ยฃ0.24 B

According to Coherus BioSciences 's latest financial reports the company's current revenue (TTM) is ยฃ0.23 B. In 2023 the company made a revenue of ยฃ0.20 B an increase over the revenue in the year 2022 that were of ยฃ0.17 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Coherus BioSciences from 2014 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ0.24 B21.52%
2023 ยฃ0.20 B15.75%
2022 ยฃ0.17 B-27.7%
2021 ยฃ0.24 B-30.77%
2020 ยฃ0.34 B29.9%
2019 ยฃ0.26 B
2018 N/A-100%
2017 ยฃ1.15 M-99.25%
2016 ยฃ0.15 B660.81%
2015 ยฃ20.25 M1.35%
2014 ยฃ19.98 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ88.13 M-62.46%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.28 M-99.88%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ23.57 B 9,939.14%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.45 B 95.48%๐Ÿ‡บ๐Ÿ‡ธ USA